Brief: Achilles Therapeutics Reports Third Quarter Financial Results
Nov 8 (Reuters) - Achilles Therapeutics Plc 698Y.F :
* ACHILLES THERAPEUTICS REPORTS THIRD QUARTER 2022 FINANCIAL
RESULTS AND RECENT BUSINESS HIGHLIGHTS
* STRONG CASH BALANCE OF $179.9 MILLION SUPPORTS ALL PLANNED
OPERATIONS INTO Q2 2025
* QTRLY LOSS PER SHARE $0.32
* Q3 EARNINGS PER SHARE VIEW $-0.55 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX7phH18
Further company coverage: 698Y.F
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Achilles Therapeutics
See all newsBrief: Achilles Therapeutics Announces Sale Of Technology Assets To Astrazeneca
Brief: Achilles Therapeutics Receives Approval To Transfer To Nasdaq Capital Market
Achilles gains on plans to explore strategic options
Brief: Achilles Therapeutics To Discontinue Development Of TIL-Based cNET Therapy
Brief: Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement